Inventor · disambiguated record
Mark Frewin
Also filed as: FREWIN MARK · FREWIN MARK R · FREWIN MARK RAYMOND
8 granted patents·9 pending applications·171 citations·filing 1997–2020
87Inventor score
Top patents by PatentIndex Score
17 records- 0196US7993641B2Methods of treatment using anti-CD3 antibodiesBTG INT LTD·Filed 2006·Granted Aug 9, 2011·47 cites·14 claims
- 0292US7994289B2Humanized anti-CD3 antibodiesBTG INT LTD·Filed 2003·Granted Aug 9, 2011·44 cites·14 claims
- 0391US7465790B2Therapeutic antibodiesISIS INNOVATION INC·Filed 2001·Granted Dec 16, 2008·67 cites·4 claims
- 0484US8440190B2Antibody variantsWALDMANN HERMAN·Filed 2005·Granted May 14, 2013·4 cites·13 claims
- 0583US8623357B2Therapeutic antibodiesWALDMANN HERMANN·Filed 2008·Granted Jan 7, 2014·8 cites·4 claims
- 0671US7947272B2Compositions and methods of tolerizing a primate to an antigenTOLERX INC·Filed 2006·Granted May 24, 2011·1 cites·21 claims
- 0769US2021269544A1Therapeutic antibodiesCYTOMX THERAPECUTICS INC·Filed 2020·Application pending·0 cites
- 0860US10800850B2Therapeutic antibodiesCYTOMX THERAPEUTICS INC·Filed 2015·Granted Oct 13, 2020·0 cites·17 claims
- 0960US2014212418A1Therapeutic AntibodiesWALDMANN HERMAN·Filed 2013·Application pending·0 cites
- 1056US7541443B2Anti-CD4 antibodiesTOLERRX INC·Filed 2003·Granted Jun 2, 2009·0 cites·13 claims
- 1153US2011282037A1Antibody preparationWALDMANN HERMAN·Filed 2011·Application pending·0 cites
- 1249US2002131968A1Antibody preparationFiled 2000·Application pending·0 cites
- 1349US2004109855A1Therapeutic antibodies with reduced side effectFiled 2003·Application pending·0 cites
- 1445US2013028893A1Therapeutic antibodies with reduced side effectWALDMANN HERMAN·Filed 2011·Application pending·0 cites
- 1544US2011008330A1Compositions and methods of tolerizing a primate to an antigenFREWIN MARK·Filed 2010·Application pending·0 cites
- 1643US2003108518A1TRX1 antibody and uses thereforFiled 2002·Application pending·0 cites
- 1727US2002048578A1Antibody variantsFiled 1997·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →